Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery

Methods. This prospective US multicenter trial of leuprolide acetate 1-month depot (7.5–15 mg) for central precocious puberty utilized an open-label treatment period, long-term follow-up, and adult callback. Forty-nine females <9 years old with Tanner breast stage ≥2 before 8 years and 6 males &l...

詳細記述

保存先:
書誌詳細
主要な著者: Neely, E. Kirk, Lee, Peter A., Bloch, Clifford A., Larsen, Lois, Yang, Di, Mattia-Goldberg, Cynthia, Chwalisz, Kristof
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2010
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3062984/
https://ncbi.nlm.nih.gov/pubmed/21437000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/398639
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料